Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-30

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for HALOPERIDOL DECANOATE from Fresenius Kabi USA, LLC (ANDA074893). The approval denotes regulatory changes to the alre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)